Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Laboratory Investigation

• Publication date

  2006-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/labinvest.3700374PMID 16344856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients

  2004cited by this paper
• Regulation of liver regeneration.

  2004cited by this paper
• Transforming growth factor-β induces contraction of activated hepatic stellate cells

  2004cited by this paper
• Lipid metabolism in hepatic steatosis.

  2004cited by this paper
• What is transforming growth factor-beta (TGF-β)?

  2004cited by this paper
• What is transforming growth factor-beta (TGF-beta)?

  2004cited by this paper
• Nonalcoholic steatohepatitis

  2004cited by this paper
• affy - analysis of Affymetrix GeneChip data at the probe level

  2004cited by this paper
• Transforming growth factor-beta induces contraction of activated hepatic stellate cells.

  2004cited by this paper
• Multiple Testing. Part II. Step-Down Procedures for Control of the Family-Wise Error Rate

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Hepatitis C and liver fibrosis

  2003cited by this paper
• Dendritic cells and immune regulation in the liver

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• Epithelial-mesenchymal transitions in development and pathologies.

  2003cited by this paper
• Resampling-based Multiple Testing for Microarray Data Analysis

  2003cited by this paper
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

  2003cited by this paper
• Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis

  2003cited by this paper
• Resampling-based multiple testing for microarray data analysis

  2003cited by this paper
• Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

  2002cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2000.

  2002cited by this paper
• Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

  2002cited by this paper
• Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?

  2002cited by this paper
• Overweight, obesity, and cancer risk.

  2002cited by this paper
• Nonalcoholic steatohepatitis.

  2001cited by this paper
• Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

  2001cited by this paper
• High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

  2001cited by this paper
• Fibrosis of liver, pancreas and intestine: common mechanisms and clear targets?

  2000cited by this paper
• Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study

  2000cited by this paper
• Cytokines in alcoholic and nonalcoholic steatohepatitis.

  2000cited by this paper
• Nonalcoholic Steatohepatitis

  1999cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice.

  1999cited by this paper
• Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

  1999cited by this paper
• Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease

  1999cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• Role of growth factors and cytokines in hepatic regeneration

  1995cited by this paper
• Resampling-Based Multiple Testing.

  1994cited by this paper
• Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment

  1993cited by this paper
• Metabolic aspects of peroxisomal beta-oxidation.

  1991cited by this paper
• Metabolic aspects of peroxisomal β-oxidation

  1991cited by this paper
• The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years

  1990cited by this paper

• Research Progress on the Relationship between Aquaporins and Coronary Heart Disease

  2024cites this paper
• Dietary zinc deficiency increases damage rate and copy number of mitochondrial DNA in the mouse liver

  2024cites this paper
• Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease

  2023cites this paper
• Bioactive peptides PDBSN improve mitochondrial function and suppression the oxidative stress in human adiposity cells

  2023cites this paper
• Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease

  2023cites this paper
• Mitochondrial DNA copy number in Hepatitis C virus-related chronic liver disease: impact of direct-acting antiviral therapy

  2023cites this paper
• Thyroid hormone action and liver disease, a complex interplay

  2023cites this paper
• Feeding Medium-Chain Fatty Acid Rich Formula Causes Liver Steatosis and Alters Hepatic Metabolism in Neonatal Pigs.

  2023cites this paper
• Investigation of FGF21 mRNA levels and relative mitochondrial DNA copy number levels and their relation in nonalcoholic fatty liver disease: a case-control study

  2023cites this paper
• Mitochondrial DNA methylation in metabolic associated fatty liver disease

  2023cites this paper
• Comparative Analysis of Global Hepatic Gene Expression in Adolescents and Adults with Non-alcoholic Fatty Liver Disease

  2022cites this paper
• Knockdown of insulin-like growth factor 2 gene disrupts mitochondrial functions in the liver

  2021influential citation
• Neutral sphingomyelinase‐2 and cardiometabolic diseases

  2021cites this paper
• The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview

  2021cites this paper
• Mitochondrial Dysfunction and Oxidative Stress in Liver Transplantation and Underlying Diseases: New Insights and Therapeutics

  2021cites this paper
• Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study.

  2021cites this paper
• Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study

  2020cites this paper
• Effect of methionine/choline-deficient diet and high-fat diet-induced steatohepatitis on mitochondrial homeostasis in mice.

  2020cites this paper
• Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model.

  2020cites this paper
• A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease

  2019cites this paper
• Role of Mitochondria in the Liver Metabolism in Obesity and Type 2 Diabetes

  2019cites this paper
• FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis

  2019cites this paper
• Marqueurs diagnostiques et pronostiques de la stéatohépatite métabolique

  2019cites this paper
• Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway

  2019cites this paper
• Investigating the Role of Mitochondria in Type 2 Diabetes - Lessons from Lipidomics and Proteomics Studies of Skeletal Muscle and Liver.

  2019cites this paper
• Mitochondrial DNA in liver inflammation and oxidative stress.

  2019cites this paper
• Evaluation of Lipid Profile In Subjets Diagnosed With Non- alcoholic Fatty Liver Disease

  2018cites this paper
• Methylation of imprinted IGF2 regions is associated with total, visceral, and hepatic adiposity in postmenopausal women

  2018cites this paper
• Molecular pathways of nonalcoholic fatty liver disease development and progression

  2018cites this paper
• Redox Signaling in NASH

  2017cites this paper
• Non-alcoholic fatty liver disease: bases for therapeutic roles of vitamin e and n-3 PUFA

  2017cites this paper
• Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients

  2017cites this paper
• Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility

  2016cites this paper
• Oxidative stress and neuropsychiatric disorders in the life spectrum

  2016cites this paper
• Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus.

  2016cites this paper
• Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models

  2016cites this paper
• Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation

  2016cites this paper
• Recent Insights into Treatment of Non-Alcoholic Steatohepatitis

  2016cites this paper
• Hepatic Mitochondrial Fatty Acid Oxidation and Type 2 Diabetes

  2016cites this paper
• Developmental programming and reversibility in early life

  2016cites this paper
• Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.

  2015cites this paper
• Vibrational signatures to discriminate liver steatosis grades.

  2015cites this paper
• Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles Perspective

  2015cites this paper
• A systems biology approach towards child obesity and obesity-related diseases: integration of clinical, genetic, hormonal and NMR metabonomic factors

  2015cites this paper
• Liver and oxidative stress

  2015cites this paper
• Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.

  2015cites this paper
• Von Hippel-Lindau status influences phenotype of liver cancers arising from PTen loss adam B sendor

  2015cites this paper
• Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

  2015cites this paper
• Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)

  2014cites this paper
• Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.

  2014cites this paper
• The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis[S]

  2014cites this paper
• Lipids in health and disease

  2014cites this paper
• Effects of Taurine Supplementation on Hepatic Markers of Inflammation and Lipid Metabolism in Mothers and Offspring in the Setting of Maternal Obesity

  2013influential citation
• Participation of aquaporin-1 in vascular changes and remodeling in cirrhotic liver

  2013cites this paper
• Glycogen synthase kinase 3‐mediated voltage‐dependent anion channel phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation

  2013cites this paper
• The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans

  2013cites this paper
• Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)

  2013cites this paper
• Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.

  2012cites this paper
• Mechanism(s) of hepatitis C virus induced liver injury

  2012cites this paper
• Non-alcoholic steatohepatitis: new insights from OMICS studies.

  2012cites this paper
• Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells.

  2012cites this paper
• Genomics and HCV infection: progression of fibrosis and treatment response.

  2012cites this paper
• GSK3-mediated VDAC phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation

  2012cites this paper
• Expression of aquaporins in rat liver regeneration

  2012cites this paper
• Systematic review of performance of non‐invasive biomarkers in the evaluation of non‐alcoholic fatty liver disease

  2011cites this paper
• Les mécanismes de réponse à l'inflammation chronique dans le foie stéatosique et les conséquences sur l'homéostasie cellulaire et la cancérogénèse

  2011cites this paper
• Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications

  2011cites this paper
• Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype.

  2011cites this paper
• Decreased immunoexpression of survivin could be a potential marker in human non‐alcoholic fatty liver disease progression?

  2011cites this paper
• Hepatic Gene Expression of Caucasian and African-American Patients with Obesity-Related Non-Alcoholic Fatty Liver Disease

  2010cites this paper
• A role for mammalian target of rapamycin (mTOR) pathway in non alcoholic steatohepatitis related-cirrhosis.

  2010cites this paper
• Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.

  2010cites this paper
• DNA microarrays to define and search for genes associated with obesity

  2010cites this paper
• Hepatic Gene Networks in Morbidly Obese Patients With Nonalcoholic Fatty Liver Disease

  2010cites this paper
• Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis

  2009cites this paper
• Thyroid hormone-related regulation of gene expression in human fatty liver.

  2009cites this paper
• Hígado graso no alcohólico: un encuadre didáctico para un problema latente (primera parte)

  2009cites this paper
• Toxicogenomic Biomarkers for Liver Toxicity

  2009cites this paper
• Mitochondrial dysfunction in nonalcoholic steatohepatitis (NASH): are there drugs able to improve it?

  2009cites this paper
• Liver-specific overexpression of the IGF2 mRNA binding protein p62 induces a fatty liver disease phenotype

  2009cites this paper
• Isoforms of Retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver

  2008cites this paper
• Adipose tissue inflammation, hepatic fat accumulation and insulin resistance

  2008cites this paper
• Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.

  2008cites this paper
• Differential Expression of Oxidative Stress and Inflammation Related Genes in Peripheral Blood Mononuclear Cells in Response to a Low-Calorie Diet: A Nutrigenomics Study

  2008cites this paper
• Emerging drugs for non-alcoholic fatty liver disease

  2008cites this paper
• Gene expression in human NAFLD.

  2008influential citation
• Gene expression profiles of murine fatty liver induced by the administration of methotrexate.

  2008cites this paper
• Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• Causes and metabolic consequences of Fatty liver.

  2008cites this paper
• Fatty Liver: A Novel Component of the Metabolic Syndrome

  2007cites this paper
• Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects

  2007cites this paper
• Idiosyncratic toxicity: a convergence of risk factors.

  2007cites this paper
• Adipose tissue inflammation is associated with immune dysfunction during influenza virus infection

  2007cites this paper
• Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.

  2007cites this paper
• The Global Hepatic Transcriptional Response of Male Fisher Rats to Dietary Aroclor 1254 Exposure

  2007cites this paper
• Application of DNA Microarrays in the Study of Human Obesity and Type 2 Diabetes

  2007cites this paper
• Aquaporins in the hepatobiliary tract. Which, where and what they do in health and disease

  2007cites this paper
• Present and future therapeutic strategies in non-alcoholic fatty liver disease

  2007cites this paper
• Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes

  2007cites this paper